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Conclusion. Bone marrow-derived cells can be engrafted in the 
olfactory bulb and a few cells can differentiate into mitral/tufted 
cells in the olfactory bulb. Objectives.  To investigate whether 
bone marrow derived-cells can be engrafted into the olfactory bulb 
and differentiate into neurons and glial cells after methimazole 
administration. Method.  Bone marrow of GFP (green 
fluorescence protein) mice was transplanted into lethally 
irradiated recipient mice. Furthermore immunostaining was 
performed to confirm the cell types of bone marrow derived-cells 
expressing GFP.  Results. GFP-positive cells were observed in 
the olfactory bulb at 2 days after methimazole administration. 
The number of dendritic GFP-positive cells increased up to 30 
days after methimazole administration and then decreased. 
Double immunostaining for GFP and Iba1 or TBX21 showed that 
a large population of the GFP-positive cells had characteristics of 
microglia/macrophage and a few cells had characteristics of 
mitral/tufted cells.  
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We have reported studies [1, 2] using bone marrow-derived cells 
for olfactory tissue regeneration. These studies have 
demonstrated that a part of donor bone marrow-derived cells 
engrafted in the olfactory epithelium of radiation-induced 
immunotolerant recipient mice had characteristics of olfactory 
receptor neurons [1] and that the early administration of G-CSF 
(granulocyte-colony stimulating factor)  after the administration 
of methimazole (anti-thyroid function and toxicity specific to 
olfactory receptor neurons) was more effective to increase the 
engraftment rate of bone marrow-derived cells into the 
regenerated olfactory epithelium [2]. We have also found quite a 
few donor-marker cells in the olfactory bulb after methimazole 
administration. 
The olfactory bulb is one of the relay sites of the olfactory 
pathway from the nose to the olfactory cortex and consists of five 
layers (glomerular layer, external plexiform layer, mitral cell 
layer, internal plexiform layer, and granule cell layer). 
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Mitral/tufted cells in the olfactory bulb, whose dendrites 
innervate the axon of olfactory receptor neurons at the glomeruli 
in the glomerular layer, relay olfactory information to the 
olfactory cortex. Apoptosis of olfactory receptor neurons after 
methimazole administration [3] induces the denervation of 
mitral/tufted cells and subsequently a fraction of these cells are 
fated to fall into cell death. 
Mesenchymal stem cells are becoming universally accepted to be 
capable of differentiating not only into non-epithelial lineages 
such as chondrocytes, adipocytes, osteocytes, myocytes, but also 
into epithelial lineages such as hepatocytes and neuron-like cells 
[4-6] although it remains controversial if the plasticity of adult 
stem cells including mesenchymal stem cells is true or seems to 
be true [7, 8]. In addition mesenchymal stem cells have been 
suggested to be engrafted in damaged tissue as tissue-specific 
stem cells because of their plasticity and circulating in the body 
[9]. However, a wave of studies focusing on the possibility of 
mesenchymal stem cells for regenerative medicine have 
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elucidated that their roles are not only transdifferentiation into 
tissue-specific cells, but also secretion of growth and 
differentiation factors, induction of immune cell-mediated 
immuno-moderation, and secretion of anti-apoptotic factors [10, 
11]. 
We transplanted bone marrow including mesenchymal stem cells 
into radiation-induced immunotolerant recipient mice and 
investigated the cell types of donor-marker positive bone 
marrow-derived cells in the olfactory bulb after methimazole 
administration. 
 
Materials and methods 
1. Bone marrow transplantation, drug administration, and tissue 
preparation 
After eight-week-old female C57BL/6 recipient mice had 
undergone 10 Gy of lethal whole-body-irradiation split into two 
doses separated by 6.5 h, they were transplanted with bone 
marrow harvested from the femurs of age- and sex-matched GFP 
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transgenic mice (C57BL/6-Tg (CAG-EGFP)). Donor bone marrow 
was resuspended in Hank’s balanced salt solution and 1×106 bone 
marrow cells were injected into the tail vein of the recipient mice. 
The recipient mice were maintained in a specific pathogen-free 
environment and received normal chow and hyper-chlorinated 
drinking water for the first 4 weeks after bone marrow 
transplantation. 
One month after bone marrow transplantation, a dose of 
methimazole (50 mg/kg) (Wako, Richmond, VA, USA) was 
peritoneally administered to damage the olfactory epithelium of 
the recipient mice. These mice were sacrificed under diethyl-ether 
anesthesia at 2 days (n=5, 2-day group), 5 days (n=5, 5-day group), 
10 days (n=5, 10-day group), 30 days (n=5, 30-day group), and 60 
days (n=5, 60-day group) after methimazole administration.  
Control mice (n=5, administration of 0.9% saline solution instead 
of methimazole, control group) were treated in the same manner 
and sacrificed at 30 days after the administration of saline 
solution. The anterior part of the head including the olfactory 
Page 6 of 27






























































For Peer Review Only
7 
 
bulb and epithelium of each mouse was then removed. After 
overnight fixation in 4% paraformaldehyde and decalcification for 
14 days in 10% EDTA (ethylenediamine-tetraacetic acid), the 
tissue samples were embedded in paraffin and 4 µm thick 
consecutive coronal cross-sections were prepared. 
All experimental protocols complied with the guidelines of the 
Okayama University’s Committee on the Use and Care of 
Animals. This research was approved (OKU-2011135) by the 
Animal Experiment Control Committee of the Okayama 
University Graduate School of Medicine and Dentistry. 
 
2. Immunohistochemistry for OMP (olfactory marker protein) or 
GFP 
After blocking endogenous peroxidase, the sections were then 
incubated in 0.1% trypsin (Difco Laboratories, Detroit, MI, UAS) 
for 5 min at 37℃. After blocking of non-specific binding sites by 
incubation in 10% normal goat serum containing 1% BSA for 15 
min, the sections were incubated overnight at 4℃ in an anti-OMP 
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goat polyclonal antibody (1:2000) (Wako Chemicals) or an 
anti-GFP rabbit polyclonal antibody (1:1000) (MBL, Nagoya, 
Japan).  
The sections were then rinsed in TBS followed by treatment with 
a rabbit anti-goat immunoglobulin antibody conjugated-HRP 
(Santa Cruz Biotechnology, LA, USA) to OMP immunostaining or 
a goat anti-rabbit immunoglobulin antibody conjugated-HRP 
(Dako, Copenhagen, Denmark) to GFP immunostaining for 30 
min. After rinsing in TBS, the sections were stained with DAB for 
15 min. 
Sections from the olfactory epithelium of the donor mice were 
used as positive controls, while negative control sections were 
processed in an identical way with the exception that the primary 
antibodies were excluded. 
 
3. Statistical analysis of bone marrow-derived cells in the 
olfactory bulb 
The engraftment rates of donor bone marrow-derived cells into 
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the olfactory bulb were calculated by counting the number of 
dendritic GFP-positive cells of the olfactory bulb per 1 mm2 in a 
representative slice of the coronal sections. Measurements were 
carried out microscopically at high magnification (X400) in 2-day, 
5-day, 10-day, 30-day, 60-day, and control groups. Data were 
expressed as medians, interquartile ranges at each group. 
Significant differences between groups were analyzed 
Kruskal-Wallis with multiple comparison test (Scheffe type that 
is based on the Kruskal-Wallis ).   
 
4. Double immunostaining for GFP and Iba1 or TBX21  
Double immunostaining for GFP and Iba1 or TBX21 was 
performed in order to confirm the cell types expressing GFP. Iba1 
and TBX21 stain the cytoplasm of microglia/macrophages [12] 
and the nuclei of mitral/tufted cells [13], respectively. 
After incubation of the sections in the anti-GFP rabbit polyclonal 
antibody (1:50) or an anti-GFP goat polyclonal antibody (Abcam, 
Cambridge, MA, USA) (1:100), an anti-Iba1 goat polyclonal 
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antibody (1:50) (Abcam, Cambridge, MA, USA) or an anti-TBX21 
rabbit polyclonal antibody (1:50) (Santa Cruz Biotechnology) was 
added. An anti-goat donkey antibody conjugated Alexa Fluor 568 
(1:250) (Invitrogen, Carlsbad, CA, USA) for Iba1 and GFP and an 
anti–rabbit chicken antibody conjugated Alexa Fluor 488 (1:200) 
(Invitrogen, Carlsbad, CA, USA) for TBX21 and GFP were used as 
the secondary antibodies. 
 
Results 
1. Temporal expression of OMP in the olfactory epithelium and 
bulb after methimazole administration 
 
The olfactory epithelium 
At 2 days after methimazole administration, OMP expression was 
found only in the olfactory axons of the submucosal layer, because 
the olfactory epithelium exfoliated from the basal layer. At 5 days 
after methimazole administration, OMP expression and 
histological findings were similar to those of 2 days after 
Page 10 of 27
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methimazole administration. At 10 days after methimazole 
administration, the regeneration of the olfactory epithelium was 
found, but OMP expression was weaker than that of the control. 
The olfactory epithelium was completely reproduced at 30 days 
after methimazole administration and OMP expression was 
recovered up to the control level. The findings of 60 days after 
methimazole administration were similar to those of 30 days after 
methimazole administration. 
 
The olfactory bulb 
Unlike the olfactory epithelium, the initial change of OMP 
expression was observed at 10 days after methimazole 
administration (Fig. 1A). Condensed OMP expression was limited 
to the atrophic glomerular layer. The histological structure and 
OMP expression of the olfactory bulb at 30 days after 
methimazole administration (Fig. 1B) were recovered up to those 
of the control. The changes of OMP expression in the olfactory 
bulb were delayed behind that of the olfactory epithelium. 
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A few round GFP-positive cells were found in the glomerular layer 
at 2 and 5 days after methimazole administration. Round 
GFP-positive cells increased after 10 days after methimazole 
administration, while a few dendritic GFP-positive cells were 
found in the glomerular layer and the external granular layer. At 
30 days after methimazole administration, a quite few dendritic 
GFP-positive cells were present in the glomerular layer and the 
external granular layer (Fig. 2), while round GFP-positive cells 
decreased. At 60 days after methimazole administration, 
dendritic GFP-positive cells also decreased.  
 
2. Statistical analysis of bone marrow-derived cells in the 
olfactory bulb 
The means and standard deviations of dendritic-form 
GFP-positive cells/mm2 of all groups were 1.32±1.34 (2-day group), 
1.46±0.07 (5-day group), 10.72±4.12 (10-day group), 29.42±15.12 
(30-day group), 15.62±9.70 (60-day group), and 2.04±1.62 (control 
group), respectively. The number of dendritic-form GFP-positive 
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cells increased up to 30 days after methimazole administration 
and afterwards decreased. Kruskal-Wallis with multiple 
comparison  showed a significant difference between mean 
values by groups (P=0.0003).  The Scheffe test, a post hoc test 
suitable for multiple comparison, showed significant differences 
between 30-day group and 2-day group (P=0.0230) or 5-day group 
(P=0.0418). Any difference between the other pairs failed to reach 
statistical significance (P<0.05) (Figure 3). 
 
3. Double-immunostaining for GFP and Iba1 or TBX21 
Double-immunostaining for GFP and Iba1 or TBX21  (Fig. 4) 
showed that numerous GFP+ Iba1+ cells were distributed in all 
layers of the olfactory bulb, while a few GFP+ TBX21+ cells were 
discovered mainly in the mitral cell layer.  The ratio of GFP+ 
TBX21+ cells to GFP+ Iba1+ cells was about 1 percent.  
 
Discussion 
Stem cell transplantation has opened the possibility of 
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regeneration medicine for intractable diseases and mesenchymal 
stem cells residing in the bone marrow or adipose tissue are 
thought to be one of the most promising stem cells because of the 
easy harvest. Blau, et al. [14] have proposed the theory that stem 
cells circulate in the body and are engrafted into a damaged organ 
as tissue-specific stem cells inherent to the damaged organ. Their 
theory has been reinforced by numerous experimental and clinical 
studies. We have also reported that the insult of the olfactory 
epithelium by methimazole increased the engraftment rate of 
bone marrow-derived cells into the regenerated olfactory 
epithelium. The present study has demonstrated that the 
influences of methimazole to the olfactory bulb occurred behind 
those to the olfactory epithelium. In other words, methimazole 
acts on olfactory receptor neurons directly and induces them to 
apoptosis, while it does not act on the olfactory bulb directly [15]. 
The morphological changes of the olfactory bulb might be caused 
mainly by the degeneration of olfactory nerve axons and partly by 
the cell death of mitral/tufted cells by subsequent denervation. As 
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a similar secondary influence for the olfactory bulb, the increase 
of GFAP in the olfactory bulb has been shown to be caused by the 
primary damage to the olfactory mucosa of methimazole- and 
dichlobenil-treated mice [15].  
Double immunostaining carried out to confirm the cell types 
expressing GFP demonstrated that all almost GFP-positive cells 
were microglia/macrophages and a few GFP-positive cells were 
mitral/tufted cells. This low frequency of transdifferentiation 
might be explained partly because only a fraction of mitral/tufted 
cells were denervated by the degeneration of olfactory axons and 
were induced to cell death. 
From our temporal observation GFP-positive cells emerged in the 
glomerular layer of the olfactory bulb at 10 days after 
methimazole administration, increased significantly at 30 days 
after methimazole administration, and decreased down to the 
initial level at 60 days after methimazole administration. This 
time dependent change seemed to demonstrate that most 
GFP-positive cells were macrophages which entered the olfactory 
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bulb to phagocytose debris of damaged olfactory axons through 
blood brain barriers damaged by the secondary influences to the 
glomerular layer of the olfactory bulb by methimazole and 
macrophages were cleaned up after the histological restoration of 
the olfactory bulb, while a fraction of these cells differentiated 
into microglia as seen in a model of ischemic retinopathy [16]. 
We transplanted bone marrow including mesenchymal stem cells 
and reported that transplanted bone marrow-derived cells 
differentiated into olfactory receptor neurons. The present study 
also demonstrated that bone marrow-derived cells differentiated 
into microglia and rarely differentiated into mitral/tufted cells.  
These results may be the first step to regeneration therapy using 
bone marrow transplantation for the secondary central dysosmia 
at the olfactory bulb although transdifferentiation to 
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Figure 1. OMP expression in the olfactory bulb. 
 (A) 10 days after methimazole administration, (B) 30 days after 
methimazole administration. Scale bar = 50µm. 
 
Figure 2. GFP-positive cells in the olfactory bulb at 30 days after 
methimazole administration.  
GFP-positive dendritic or round cells are mixed in the olfactory 
bulb, but the ratio of dendritic cells is superior. The inlet 
magnifies the dendritic cell indicated by the arrow.  
Scale bar = 100µm. 
 
Figure 3. The number of dendritic GFP-positive cells at each time 
point after methimazole administration. 
Data were expressed as medians , interquartile ranges at each 
stage AMA. Significant differences between both stages were 
analyzed using Kruskal-Wallis with multiple comparison.   
* P<0.05 ,  *** P<0.001 
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Figure 4. Double immunostaining for GFP and Iba1 or TBX21 in 
the olfactory bulb on 30 days after methimazole administration. 
(A, D) GFP staining. (B) Iba1 staining. (C) Superimposing of GFP 
(green) and Iba1 (red) shows co-localization (orange). 
Superimposed image shows that a part of the donor bone 
marrow-derived cells became microglia/macrophages in the 
olfactory bulb. DAPI staining. (blue). (E) TBX21 staining. (F) 
Superimposing of GFP (red) and TBX21（green） shows 
co-localization (orange). Superimposed image shows that a 
fraction of the donor bone marrow-derived cells became 
mitral/tufted cells in the olfactory bulb. DAPI staining (blue).  
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